Changing Paradigms In Hereditary Angioedema: A Focus On Timely Diagnosis And New Therapies

Main Category: Immune System / Vaccines
Also Included In: Complementary Medicine / Alternative Medicine
Article Date: 10 Jul 2009 - 2:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:3 and a half stars

3.5 (2 votes)

Healthcare Prof:5 stars

5 (1 votes)


Hereditary angioedema (HAE) is an autosomal dominant disease affecting approximately 10,000 people in the United States. HAE causes recurrent attacks of intense localized edema involving the skin, airway, and visceral organs. While chronic therapy with attenuated androgens or plasmin inhibitors has been the mainstay of HAE therapy, many new therapies for prophylaxis and acute treatment are on the horizon. It is important for physicians to understand the signs and symptoms of patients who present with HAE and to be familiar with the conventional and emerging therapies available to treat them.

To address the need for current education on HAE, Robert Michael Educational Institute LLC (RMEI) and Postgraduate Institute for Medicine (PIM) are jointly sponsoring a complimentary continuing medical education self-study audio activity titled Changing Paradigms in Hereditary Angioedema: A Focus on Timely Diagnosis and New Therapies. This activity is supported by an educational grant from ViroPharma Incorporated.

Faculty for this continuing medical education activity include the following experts in allergy and immunology: Allen P. Kaplan, MD, from Medical University of South Carolina in Charleston, South Carolina; Bruce L. Zuraw, MD, from the University of California School of Medicine in San Diego, California; and Paula J. Busse, MD, from the Mount Sinai School of Medicine in New York.

"Quality continuing medical education is vital to developing and increasing knowledge and skills and enhancing patient care," says Robert Michael Educational Institute LLC President and CEO, Robert M. Colleluori.

RMEI is a medical education company that specializes in independent, certified and non-certified education. The goal of all certified RMEI educational offerings is to promote a spirit of lifelong learning and continuous professional development. RMEI works closely with medical experts to design activities that improve diagnosis and treatment leading to better outcomes for patients. These activities include national and international symposia, teleconferences, live meetings, enduring print materials, and interactive Internet programs.

Source: Robert Michael Educational Institute LLC

Article adapted by Medical News Today from original press release.
Visit our immune system / vaccines section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Robert Michael Educational Institute LLC. "Changing Paradigms In Hereditary Angioedema: A Focus On Timely Diagnosis And New Therapies." Medical News Today. MediLexicon, Intl., 10 Jul. 2009. Web.
12 Feb. 2012. <http://www.medicalnewstoday.com/releases/157032.php>

APA
Robert Michael Educational Institute LLC. (2009, July 10). "Changing Paradigms In Hereditary Angioedema: A Focus On Timely Diagnosis And New Therapies." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/157032.php.

Please note: If no author information is provided, the source is cited instead.


Immune System / Vaccines

Most Popular Articles



Follow Our Immune System News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Immune System / Vaccines Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »